Pfizer, BioNTech partner for mRNA shingles vaccine

2022-01-11

Partners Pfizer and BioNTech have unveiled plans to produce a shingles vaccine using mRNA technology. The collaboration will have Pfizer paying BioNTech $225 million, which includes a $150 million equity investment.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.